Aplus Consultant Company Profile, Services & Reviews

Overview

Aplus is a management consulting firm focused on transforming global healthcare and beyond. We leverage leading-edge analytics, data, and science to help clients make intelligent decisions.While most companies struggle with information overload, stakeholder misalignment, and quickly obsolete markets. Our extensive global network of Kol pool, with more than 150,000 experts worldwide. We will gain in-depth market insight by connecting directly with top experts.We have a global resource network, and a former IMS senior consulting and data analysis background team provides strategic support to better realize data mining and analysis with consulting thinking; It has established good cooperation relations and networks with government agencies, local enterprises, multinational companies and investment institutions, and has many successful cooperation cases; The company’s management and business...

Locations

Headquarter

848 west huntington drive Arcadia California United States 91007
+1 626 354 7275

Focus Area

Browse, Compare, Shortlist, and Hire your ideal business partner with ease.

Focus Service

Focus Client

Small Business (<$100000) 100%

Focus Industry

Information Technology 80%
Business Services 20%

Portfolio

Browse, Compare, Shortlist, and Hire your ideal business partner with ease.

Develop digital strategy and establish valuation model

Challenge: The client is a high-tech company based in Hangzhou, integrating scientific research, technological innovation, and development. The company focuses on fields such as healthcare, big data, IoT, blockchain, and artificial intelligence (AI). With a leading R&D team, they hold several self-developed core technologies and intellectual property rights. Currently, their key products include an intelligent hospital bed system, computer software systems, and a blockchain-based bi-directional traceability system. Their goal is to become a comprehensive health management solution provider in China. Solution: We conducted market and sales research to identify potential market opportunities. Through initial investigations and interviews with relevant personnel, we clarified product pricing strategies and entry barriers, using similar cases to understand product positioning. We analyzed existing competitors and their digital strategies in the market. Finally, we summarized findings from primary and secondary research, determined product value, and drafted a white paper. Outcome: We helped the client develop a clear business development strategy. The client used the PowerPoint presentation we prepared to report to the Industry Bureau and established a valuation model for investment negotiations.

Industry :
- Information Technology

Develop digital strategy and establish valuation model

Find a new entry point into the Chinese antiemetic Market

Challenge: The client, a European pharmaceutical company specializing in supportive cancer therapies, has a product (Product X) that may be approved for anti-emetic use in China in 2-3 years. They need to understand the current landscape of the anti-emetic drug market in China, how it may evolve, and assess the commercial opportunities for Product X. The objectives are to: 1) Explore the current and future anti-emetic drug market in China; 2) Evaluate the commercial opportunities for Product X and define the optimal pricing strategy; 3) Forecast Product X’s sales revenue over a 10-year period under three scenarios (worst, base, and best case). Solution: We conducted desktop research and IMS data analysis to provide a preliminary market outlook and establish key hypotheses, as well as created a discussion guide. We calculated patient flow and conducted comparative studies to analyze sales and price trends, laying the groundwork for a sales forecasting model. We interviewed key opinion leaders (KOLs) and conducted competitive intelligence (CI) interviews to understand pricing, entry barriers, and product positioning in the treatment landscape. Finally, we summarized key insights to deliver a high-level market strategy and designed a net present value (NPV) model for potential collaboration. Outcome: Our model estimated the commercial value of Product X to be 200% higher than the client’s original assumption. This allowed the client to segment the market by different metrics (postoperative nausea and vomiting, and chemotherapy-induced nausea and vomiting), identify key factors for hospital listing, and compile a list of potential Chinese partners for collaboration.

Industry :
- Information Technology

Find a new entry point into the Chinese antiemetic Market

Successfully acquired American health products company

Challenge: The client is a leading pharmaceutical company in China, with steadily growing sales revenue in recent years but lacking core competitiveness. They aim to create more value from their existing sales channels, expand into overseas markets, and maximize the value of their premium products. The client is looking to acquire a U.S. company to produce high-quality health supplements and promote their products internationally. However, they lack a clear estimate of the growth potential and value of the target overseas market and have limited experience negotiating with business and trade partners. Solution: We analyzed epidemiological data, clinical practices, market trends, product pricing, and market share to forecast the product’s sales performance in overseas markets. By referencing the pricing of similar products in the target market, we assessed price sensitivity to provide an initial pricing recommendation for the local market entry and forecast price changes over the next few years. Through an evaluation of projected sales performance, clinical and marketing costs, we estimated the product’s value range between 1,500K to 5,000K USD and proposed a suitable business structure. Outcome: Considering the value of the client’s product, we provided a list of potential partners within the U.S. health supplement industry for collaboration on the client’s production line. The negotiation evidence and communication channels we supplied enabled the client to successfully engage in discussions with U.S. companies. The target product is expected to enrich the client’s product line and help expand their business in the U.S. market, generating an estimated $1 million in revenue within three years.

Industry :
- Information Technology

Successfully acquired American health products company

Help new R & D products enter the US market smoothly

Challenge: The client is an innovative pharmaceutical company from Taiwan that is developing a transdermal patch for the treatment of Alzheimer’s disease, with plans to launch the product in the U.S. market within the next five years. However, due to a lack of knowledge about the U.S. market and legal requirements, the client is uncertain about how to enter the market. Additionally, the client seeks to better understand the product’s market value to gain a stronger negotiating position in future partnerships. Solution: We conducted market and sales research to identify market opportunities and developed an interview schedule. Through preliminary research and interviews with relevant stakeholders, we clarified the pricing strategy and identified entry barriers while analyzing similar therapies to understand the product’s market positioning. We then summarized the findings from both the initial and secondary research, determining the product’s value and market positioning, and created a net present value (NPV) model for the product, which included the best-case, worst-case, and normal-case scenarios. Outcome: Our client gained a clear understanding of the product’s commercial value. With our assistance, they established an NPV model and estimated the market value to be approximately $3 million. As a result, the client decided to select us as their consulting advisor and negotiated a partnership agreement.

Industry :
- Information Technology